The European Bank for Reconstruction and Development (EBRD) announced yesterday it would extend an 80 million euro ($90 million) loan for the construction of a new high-tech hospital in the southeastern Turkish province of Gaziantep, near the Syria-Turkey border.
"It has recently seen a sharp increase in population, partly due to the influx of refugees from neighboring Syria. The rapid population growth is putting a serious strain on healthcare services," the bank said in a statement.
According to the EBRD, the hospital was expected to benefit Gaziantep's population of close to 2 million people.
A private investor will build and maintain a health campus worth 600 million euros ($672 million), while Turkey's ministry of health would provide medical services under a public-private partnership model, EBRD said. The new Gaziantep hospital, which will consist of a general hospital, a women's and children's hospital, as well as a cardiovascular and oncology wing, is expected to be operational in 2020, it said. It is expected to have a total of 1,875 beds.
"Refugees in Turkey have access to the same cost-free medical treatment in public hospitals as local citizens, regardless of the insurance coverage available to them, and so are expected to benefit equally from the new hospital," EBRD added. According to the EBRD, the European Investment Bank (EIB) is also supporting the project, with 120 million euros ($134 million). Investors in the project include South Korea's Samsung C&T Corporation, Italian industrial group Salini Impregilo S.p.A, Turkish industrial construction company Kayi Insaat Sanayii ve Ticaret A.S. and the Korea-Turkey Gaziantep Healthcare Private Equity Investment Fund (PEIF), the EBRD said. Since 2009, the EBRD has supported more than 230 infrastructural projects, energy, agribusiness, industry and finance in Turkey.